Personalised Medicine between Europe and China (IC2PerMed)

Personalised medicine is a comprehensive approach that tailors the prevention, diagnosis and treatment of diseases to the individual using new biomedical and digital technologies. For personalised medicine to become an opportunity for citizens and patients, stakeholders need to network at international level to develop and define common research and development approaches, standards and priorities.

In order to respond to these challenges, the European Commission promoted the exchange between the European Union and the People's Republic of China with the IC2PerMed project (Integrating China in the International Consortium for Personalized Medicine).

The project partners developed a strategic roadmap and identified facilitators and barriers for collaboration between the European Union and the People's Republic of China to establish a common ground for broader implementation of topics in personalized medicine. The goal was to develop a joint strategy, advance common policy goals, and launch bilateral research projects.

As a project partner, Steinbeis Europa Zentrum supported the identification and mapping of the various initiatives, regulatory frameworks and strategies on both the European and Chinese sides. The SEZ's other competencies included the organisation of various expert forums dedicated to the development of European-Chinese standards.

Further information: